T. Houben, Ph.D.
Recente publicaties
-
Peters, L., Rakateli, L., Huchzermeier, R., Bonnin-Marquez, A., Maas, S. L., Lin, C., Jans, A., Geng, Y., Gorter, A., Gijbels, M., Rensen, S., Olinga, P., Hendrikx, T., Krawczyk, M., Brisbois, M., Jankowski, J., Bidzhekov, K., Weber, C., Biessen, E. A. L., ... van der Vorst, E. (2025). MicroRNA-26b protects against MASH development in mice and can be efficiently targeted with lipid nanoparticles. Elife, 13. https://doi.org/10.7554/eLife.97165Meer informative over deze publicatie
-
Vermeulen, I., Li, M., van Mourik, H., Yadati, T., Eijkel, G., Balluff, B., Godschalk, R., Temmerman, L., Biessen, E. A. L., Kulkarni, A., Theys, J., Houben, T., Cillero-Pastor, B., & Shiri-Sverdlov, R. (2025). Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction-associated steatohepatitis. FEBS Journal, 292(7), 1781-1797. https://doi.org/10.1111/febs.17358Meer informative over deze publicatie
-
Li, M., Houben, T., Bitorina, A. V., Meesters, D. M., Israelsen, M., Kjærgaard, M., Koek, G. H., Hendrikx, T., Verbeek, J., Krag, A., Thiele, M., & Shiri-Sverdlov, R. (2024). Plasma cathepsin D as an early indicator of alcohol-related liver disease. JHEP Reports, 6(9), Article 101117. https://doi.org/10.1016/j.jhepr.2024.101117Meer informative over deze publicatie
-
van der Heijden, A. R., & Houben, T. (2023). Lipids in major depressive disorder: new kids on the block or old friends revisited? Frontiers in Psychiatry, 14(1), Article 1213011. https://doi.org/10.3389/fpsyt.2023.1213011Meer informative over deze publicatie
-
Groenen, A. G., La Rose, A. M., Li, M., Bazioti, V., Svendsen, A. F., Kloosterhuis, N. J., Ausema, A., Pranger, A., Heiner-Fokkema, M. R., Niezen-Koning, K. E., Houben, T., Shiri-Sverdlov, R., & Westerterp, M. (2022). Elevated granulocyte-colony stimulating factor and hematopoietic stem cell mobilization in Niemann-Pick type C1 disease. Journal of Lipid Research, 63(2), Article 100167. https://doi.org/10.1016/j.jlr.2021.100167Meer informative over deze publicatie
-
Ding, L., Oligschlaeger, Y., Shiri-Sverdlov, R., & Houben, T. (2022). Nonalcoholic Fatty Liver Disease. In A. von Eckardstein, & C. J. Binder (Eds.), Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets (Vol. 270, pp. 233-269). Springer. https://doi.org/10.1007/164_2020_352Meer informative over deze publicatie
-
Barthelemy, A., Demais, V., Stancu, I. C., Vasile, E., Houben, T., Reber, M., Pallottini, V., Perraut, M., Reibel, S., & Pfrieger, F. W. (2021). Glial contribution to cyclodextrin-mediated reversal of cholesterol accumulation in murine NPC1-deficient neurons in vivo. Neurobiology of Disease, 158, Article 105469. https://doi.org/10.1016/j.nbd.2021.105469Meer informative over deze publicatie
-
Ahmad, F., Mitchell, R. D., Houben, T., Palo, A., Yadati, T., Parnell, A. J., Patel, K., Shiri-Sverdlov, R., & Leake, D. S. (2021). Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice. Journal of the American Heart Association, 10(18), Article e017524. https://doi.org/10.1161/JAHA.120.017524Meer informative over deze publicatie
-
Houben, T., Yadati, T., De Kruijf, R., Gijbels, M. J. J., Luiken, J. J. F. P., Van Zandvoort, M., Kapsokalyvas, D., Lutjohann, D., Westerterp, M., Plat, J., Leake, D., & Shiri-Sverdlov, R. (2021). Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment. Frontiers in Immunology, 12, Article 716357. https://doi.org/10.3389/fimmu.2021.716357Meer informative over deze publicatie
-
Ding, L., De Munck, T. J. I., Oligschlaeger, Y., Verbeek, J., Koek, G. H., Houben, T., & Shiri-Sverdlov, R. (2021). Insulin resistance is positively associated with plasma cathepsin D activity in NAFLD patients. Biomolecular Concepts, 12(1), 110-115. https://doi.org/10.1515/bmc-2021-0011Meer informative over deze publicatie